Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10347935
[patent_doc_number] => 20150232941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHOD OF DIAGNOSING CANCER COMPRISING DETECTION OF THE METHYLATION SIGNATURE IN THE HTERT PROMOTER'
[patent_app_type] => utility
[patent_app_number] => 14/403802
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7866
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403802 | Method of diagnosing cancer comprising detection of the methylation signature in the hTERT promoter | May 23, 2013 | Issued |
Array
(
[id] => 9476770
[patent_doc_number] => 20140134232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'Encapsulation of Plasmid DNA (Lipogenes™) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes'
[patent_app_type] => utility
[patent_app_number] => 13/900433
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 31406
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900433
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900433 | Encapsulation of plasmid DNA (lipogenesâ„¢) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes | May 21, 2013 | Issued |
Array
(
[id] => 9042465
[patent_doc_number] => 20130245103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF FACTOR IX'
[patent_app_type] => utility
[patent_app_number] => 13/897362
[patent_app_country] => US
[patent_app_date] => 2013-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 48168
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897362
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897362 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF FACTOR IX | May 17, 2013 | Abandoned |
Array
(
[id] => 11880769
[patent_doc_number] => 09751928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Enhanced affinity T cell receptors and methods for making the same'
[patent_app_type] => utility
[patent_app_number] => 14/398206
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 15229
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398206 | Enhanced affinity T cell receptors and methods for making the same | May 1, 2013 | Issued |
Array
(
[id] => 9107091
[patent_doc_number] => 20130280223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'FUNCTIONALIZED TISSUE MATRICES'
[patent_app_type] => utility
[patent_app_number] => 13/865629
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12484
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865629 | Functionalized tissue matrices | Apr 17, 2013 | Issued |
Array
(
[id] => 13079783
[patent_doc_number] => 10059950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Compositions comprising an internalizing nucleic acid molecule, and their methods of use
[patent_app_type] => utility
[patent_app_number] => 14/394797
[patent_app_country] => US
[patent_app_date] => 2013-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394797 | Compositions comprising an internalizing nucleic acid molecule, and their methods of use | Apr 16, 2013 | Issued |
Array
(
[id] => 11880998
[patent_doc_number] => 09752159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Stable expression system for eukaryotic cells'
[patent_app_type] => utility
[patent_app_number] => 14/388936
[patent_app_country] => US
[patent_app_date] => 2013-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4879
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388936
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388936 | Stable expression system for eukaryotic cells | Mar 31, 2013 | Issued |
Array
(
[id] => 9033783
[patent_doc_number] => 20130236421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'ORAL DOSAGE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/846768
[patent_app_country] => US
[patent_app_date] => 2013-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6036
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/846768 | Oral dosage composition | Mar 17, 2013 | Issued |
Array
(
[id] => 9916794
[patent_doc_number] => 20150071999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'Novel RNAi Molecule Delivery Platform Based on Single-siRNA and shRNA Nanocapsules'
[patent_app_type] => utility
[patent_app_number] => 14/385430
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14674
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14385430
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/385430 | RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules | Mar 14, 2013 | Issued |
Array
(
[id] => 9437820
[patent_doc_number] => 20140115728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES'
[patent_app_type] => utility
[patent_app_number] => 13/804365
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8534
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13804365
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/804365 | DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9930857
[patent_doc_number] => 20150079050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'METHOD FOR PRODUCING VIRAL VECTOR'
[patent_app_type] => utility
[patent_app_number] => 14/381721
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6459
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381721
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381721 | Method for producing viral vector | Mar 13, 2013 | Issued |
Array
(
[id] => 9135690
[patent_doc_number] => 20130296405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Compounds Having Anti-Adhesive Effects on Cancer Cells'
[patent_app_type] => utility
[patent_app_number] => 13/830595
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15432
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830595
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/830595 | Compounds Having Anti-Adhesive Effects on Cancer Cells | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9909032
[patent_doc_number] => 20150064233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'LIPID-COATED NUCLEIC ACID NANOSTRUCTURES OF DEFINED SHAPE'
[patent_app_type] => utility
[patent_app_number] => 14/387645
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12599
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387645
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/387645 | Lipid-coated nucleic acid nanostructures of defined shape | Mar 12, 2013 | Issued |
Array
(
[id] => 12143828
[patent_doc_number] => 09878056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Modified polynucleotides for the production of cosmetic proteins and peptides'
[patent_app_type] => utility
[patent_app_number] => 14/390103
[patent_app_country] => US
[patent_app_date] => 2013-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 201891
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390103
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390103 | Modified polynucleotides for the production of cosmetic proteins and peptides | Mar 8, 2013 | Issued |
Array
(
[id] => 10505273
[patent_doc_number] => 09233132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Lung cancer therapy using an engineered respiratory syncytial virus'
[patent_app_type] => utility
[patent_app_number] => 13/790278
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 2532
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790278
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/790278 | Lung cancer therapy using an engineered respiratory syncytial virus | Mar 7, 2013 | Issued |
Array
(
[id] => 9162271
[patent_doc_number] => 20130310548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'NUCLEIC ACID CONSTRUCT AND METHOD OF PREPARING NANOPARTICLE USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/771374
[patent_app_country] => US
[patent_app_date] => 2013-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4133
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13771374
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/771374 | Nucleic acid construct and method of preparing nanoparticle using the same | Feb 19, 2013 | Issued |
Array
(
[id] => 8977576
[patent_doc_number] => 20130211006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Conjugated Polymeric Particle and Method of Making Same'
[patent_app_type] => utility
[patent_app_number] => 13/763066
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10801
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763066
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/763066 | Conjugated polymeric particle and method of making same | Feb 7, 2013 | Issued |
Array
(
[id] => 9900958
[patent_doc_number] => 20150056158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'BRANCHED POLYMERS'
[patent_app_type] => utility
[patent_app_number] => 14/376360
[patent_app_country] => US
[patent_app_date] => 2013-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26294
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376360
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376360 | BRANCHED POLYMERS | Jan 31, 2013 | Abandoned |
Array
(
[id] => 8842207
[patent_doc_number] => 20130137835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'Preparation of Polyphosphazene Microspheres'
[patent_app_type] => utility
[patent_app_number] => 13/745956
[patent_app_country] => US
[patent_app_date] => 2013-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3260
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/745956 | Preparation of Polyphosphazene Microspheres | Jan 20, 2013 | Abandoned |
Array
(
[id] => 9280347
[patent_doc_number] => 20140030315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'NANOFIBER SCAFFOLDS FOR BIOLOGICAL STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 13/740913
[patent_app_country] => US
[patent_app_date] => 2013-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5273
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13740913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/740913 | Nanofiber scaffolds for biological structures | Jan 13, 2013 | Issued |